Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD

Clinical trial NCT07046338 · RECRUITING

Trial details

NCT number: NCT07046338
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Metachromatic Leukodystrophy (MLD)

Start date: 2025-06-01
Primary completion: 2025-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.